|
26
|
115
|
8wguA |
Crystal structure of v30m-ttr in complex with compound 20 |
|
28
|
115
|
8wgtA |
Crystal structure of v30m-ttr in complex with compound 7 |
|
25
|
115
|
8wgsA |
Crystal structure of v30m-ttr in complex with compound 4 |
|
26
|
116
|
8pmaA |
Crystal structure of human v30m transthyretin in complex with pitb (pharmacokinetically improved ttr binder) |
|
26
|
116
|
8pm9A |
Crystal structure of human wild type transthyretin in complex with pitb (pharmacokinetically improved ttr binder) |
|
27
|
116
|
8pm8A |
V30m transthyretin structure in complex with tolcalpone |
|
28
|
116
|
8pmoA |
Crystal structure of human v122i transthyretin in complex with pitb (pharmacokinetically improved ttr binder) |
|
28
|
115
|
8jokA |
Crystal structure of v30l mutated human transthyretin |
|
27
|
115
|
8jqwA |
Crystal structure of v30i mutated human transthyretin |
|
28
|
115
|
8jnuA |
Crystal structure of v30g mutated human transthyretin |
|
26
|
116
|
8w1nA |
Structure of transthyretin pathogenic mutation a120s |
|
23
|
116
|
8w2wA |
Structure of transthyretin synthetic mutation a120l |
|
0
|
114
|
8gbrA |
Cardiac amyloid fibrils extracted from a wild-type attr amyloidosis patient |
|
0
|
113
|
8g9rA |
Cardiac amyloid fibrils extracted from a wild-type attr amyloidosis patient |
|
19
|
117
|
8ve0A |
Human transthyretin covalently modified with a2-derived stilbene in the compressed conformation |
|
26
|
116
|
8c86A |
Crystal structure of human transthyretin in complex with 3-o-methyltolcapone analogue 2 |
|
26
|
115
|
8i00A |
Crystal structure of a97s transthyretin |
|
26
|
115
|
8i0oA |
Crystal structure of transthyretin variant a97s in monomeric form |
|
28
|
116
|
8c85A |
Crystal structure of human transthyretin in complex with 3-o-methyltolcapone analogue 1 |
|
29
|
115
|
7erkA |
Crystal structure of v30m-ttr in complex with dasatinib |
|
26
|
115
|
7erhA |
Crystal structure of wt-ttr in complex with bithionol |
|
28
|
115
|
7erjA |
Crystal structure of v30m-ttr in complex with dichlorophen |
|
29
|
115
|
7eriA |
Crystal structure of v30m-ttr in complex with triclabendazole |
|
2
|
113
|
7ob4A |
Cryo-em structure of a twisted-dimer transthyretin amyloid fibril from vitreous body of the eye |
|
1
|
115
|
8tdoA |
Cryo-em structure of cardiac amyloid fibril from a variant attr i84s amyloidosis patient-3, variant-type morphology |
|
1
|
114
|
8tdnA |
Cryo-em structure of cardiac amyloid fibril from a variant attr i84s amyloidosis patient-3, wild-type morphology |
|
0
|
113
|
8pkgA |
Attrv122i amyloid fibril from hereditary attr amloidosis |
|
1
|
113
|
8pkfA |
Attrg47e amyloid fibril from hereditary attr amloidosis |
|
1
|
113
|
8pkeA |
Attrv20i amyloid fibril from hereditary attr amloidosis |
|
28
|
116
|
8w45A |
X-ray crystal structure of v30m-ttr in complex with pinostilbene |
|
26
|
115
|
8w43A |
X-ray crystal structure of v30m-ttr in complex with piceatannol |
|
27
|
116
|
8w44A |
X-ray crystal structure of v30m-ttr in complex with oxyresveratrol |
|
27
|
115
|
8w46A |
X-ray crystal structure of v30m-ttr in complex with pterostilbene |
|
26
|
116
|
8w48A |
Neutron and x-ray joint structure of wt-ttr in complex with piceatannol |
|
27
|
115
|
8w42A |
X-ray crystal structure of v30m-ttr in complex with resveratrol |
|
26
|
116
|
8w47A |
X-ray crystal structure of v30m-ttr in complex with isorhapontigenin |
|
1
|
113
|
8e7eA |
Cryo-em structure of cardiac amyloid fibril from a variant attr i84s amyloidosis patient |
|
1
|
113
|
8e7dA |
Cryo-em structure of wild-type transthyretin amyloid from heart tissue |
|
1
|
112
|
8e7hA |
Cryo-em structure of cardiac amyloid fibril from a wild-type amyloidosis patient |
|
1
|
111
|
8e7jA |
Cryo-em structure of cardiac amyloid fibril from a variant attr i84s amyloidosis patient |
|
28
|
116
|
8awiA |
Crystal structure of human transthyretin at 1.15 angstrom resolution |
|
27
|
114
|
8hejA |
Crystal structure of transthyretin in complex with a covalent inhibitor trans-styrylpyrazole |
|
27
|
116
|
8ig1A |
Crystal structure of wild-type transthyretin in complex with rafoxanide |
|
23
|
116
|
8t5xA |
Probing the dissociation pathway of a kinetically labile transthyretin mutant (a25t) |
|
27
|
115
|
8awwA |
Transthyretin conjugated with a tafamidis derivative |
|
28
|
115
|
8ii1A |
Crystal structure of v30m-ttr in complex with bid |
|
26
|
115
|
8ii3A |
Crystal structure of v30m-ttr in complex with 6-hydroxy bid |
|
25
|
115
|
8ii2A |
Crystal structure of v30m-ttr in complex with bbm |
|
27
|
115
|
8ii4A |
Crystal structure of v30m-ttr in complex with 6-hydroxy bbm |
|
25
|
114
|
8hy4A |
Crystal structure of human transthyretin variant a97s at ph 7.6 |
